# OnCo record azd0120 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/azd0120/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "azd0120" ;
  schema:name "AZD0120"@en ;
  schema:description "AZD0120 is a car-t cell therapy from AstraZeneca, in registered phase 3 trials for multiple myeloma."@en ;
  schema:url <https://onco.cc/drugs/azd0120/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=AZD0120> ;
  onco:status "phase-3" ;
  onco:tag "pipeline", "ctgov-ingest", "registry-only" ;
  onco:modality "CAR-T cell therapy" ;
  onco:cancers <https://onco.cc/cancers/multiple-myeloma/> ;
  onco:targets <https://onco.cc/targets/cd19/>, <https://onco.cc/targets/bcma/> ;
  onco:companies <https://onco.cc/companies/astrazeneca/> ;
  onco:trials <https://onco.cc/trials/nct07391657/>, <https://onco.cc/trials/nct07764978/>, <https://onco.cc/trials/nct05850234/> .